热门资讯> 正文
由于CMS降低2027年实验室服务费率,Labcorp、Quest股价下跌
2026-09-22 05:13
- Labcorp Holdings (LH) and Quest Diagnostics (DGX) are down in after-hours trading Monday after CMS announced it is reducing Medicare payment rates for laboratory services starting in 2027.
- Preliminary rates are 15% below what they are for 2026. By law, rates cannot decline by more than 15% annually. With the reduction, CMS said it will save $1B a year.
- The agency added that it has been paying ~16% more than private payors for lab services.
- "Congress created a process in 2014 requiring CMS to periodically update the payment rates for most laboratory services based on what private payors actually pay for those same services," a CMS news release states. "However, due to legislative delays, that process has been used only once for these tests."
- Since 2014, private sector rates for lab tests have dropped significantly, according to the agency.
- Labcorp is down ~5%, while Quest is off ~7%.
More on Labcorp Holdings, Quest Diagnostics
- Labcorp Holdings Inc. (LH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference Transcript
- Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- Labcorp buys MLM Medical Labs
- Labcorp forecasts 2026 adjusted EPS of $18.10-$18.55 as it raises revenue growth outlook to 5.4%-6.3%
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。